FTC says consumers would save $35 billion if drug patent ‘pay-to-delay’ settlements end
June 23rd, 2009The chairman of the Federal Trade Commission says eliminating lucrative patent settlements between brand-name and generic drug companies would save consumers $3.5 billion annually.
Posted in Medical Malpractice Expert |